{
  "id": 6253369,
  "title": "Pharma major Novartis plummets 10%, heading for worst day on record after three drug trial setbacks",
  "url": "https://urgent.news/2026/09/08/pharma-major-novartis-plummets-10-heading-for-worst-day-on-record",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-08T08:13:24.000Z",
  "source": {
    "name": "CNBC World",
    "slug": "cnbc-world",
    "url": "https://www.cnbc.com/2026/09/08/novartis-novn-del-desiran-drug-trial.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Shares of Novartis tanked on Tuesday after results from its del-desiran drug trial disappointed investors.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "BioPharma Dive",
        "title": "Novartis, Ionis drug failure spurs questions about an emerging class of heart medicines",
        "url": "https://urgent.news/2026/09/05/novartis-ionis-drug-failure-spurs-questions-about-an-emerging-class",
        "published": "2026-09-05T16:51:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}